Amgen is Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive. Amgen Inc (Symbol: AMGN) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

But making Amgen Inc an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of AMGN entered into oversold territory, changing hands as low as $256.88 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In the case of Amgen Inc, the RSI reading has hit 29.3 by comparison, the universe of dividend stocks covered by Dividend Channel currently has an average RSI of 53.6. A falling stock price all else being equal creates a better opportunity for dividend investors to capture a higher yield. Indeed, AMGN's recent annualized dividend of 8.52/share (currently paid in quarterly installments) works out to an annual yield of 3.28% based upon the recent $259.70 share price.